AI assistant
Sending…
DEXCOM INC — Director's Dealing 2012
Mar 12, 2012
30198_dirs_2012-03-12_f83302b2-f956-4258-a818-1032b3192a9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2012-03-08
Reporting Person: DOORDAN MARTIN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-08 | Common Stock | P | 1000 | $10.34 | Acquired | 5000 | Indirect |
| 2012-03-08 | Common Stock | P | 1000 | $10.369 | Acquired | 6000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 21641 | Direct |
Footnotes
F1: Shares are held by The Martin L. Doordan Rev Trust u/a 04/18/1997 As Amended, with respect to which the reporting person is a trustee.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17